Skip to main content
Neogen Chemicals Limited logo

Neogen Chemicals Limited — Investor Relations & Filings

Ticker · NEOGEN ISIN · INE136S01016 LEI · 335800PFY9B77Z2GOK22 BSE.NS Manufacturing
Filings indexed 707 across all filing types
Latest filing 2025-08-02 Investor Presentation
Country IN India
Listing BSE.NS NEOGEN

About Neogen Chemicals Limited

https://neogenchem.com/

Neogen Chemicals Limited specializes in the development and large-scale manufacturing of bromine-based and lithium-based specialty chemicals. The product portfolio includes a diverse range of bromine derivatives, lithium salts, Grignard reagents, and advanced intermediates. These products serve critical roles in pharmaceutical, agrochemical, and engineering applications. The company has expanded its operations into the energy storage market, focusing on the production of electrolytes and lithium salts for lithium-ion batteries. With a strong emphasis on research and development, the firm provides custom synthesis and contract manufacturing services to global innovators. Manufacturing capabilities are supported by multi-product facilities designed to meet stringent quality standards for complex chemical processes and high-purity requirements.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 95% confidence The document is titled as an "Earnings Presentation on the Un-Audited Financial Results of the Company for the quarter ended June 30, 2025," which clearly indicates it is a presentation related to quarterly financial results. It contains detailed financial performance data for Q1 FY26, including revenue, EBITDA, PAT, and segment-wise analysis. It also includes management commentary and updates on expansion initiatives. The document is about 15,000 characters long, which is substantial and contains actual financial data and analysis, not just an announcement or a brief summary. Therefore, it fits the definition of an Investor Presentation (IP) rather than a simple Earnings Release (ER) or Interim Report (IR), as it is a detailed presentation focusing on financials, strategy, and market position. The presence of detailed slides and commentary supports classification as an Investor Presentation.
2025-08-02 English
Investor Presentation
Interim / Quarterly Report Classification · 95% confidence The document is titled as an "Earnings Presentation on the Un-Audited Financial Results of the Company for the quarter ended June 30, 2025." It contains detailed financial performance data for Q1 FY26, including revenue, EBITDA, PAT, and segment-wise financials. It also includes management commentary, updates on expansion initiatives, and other operational highlights. The document is about 15,000 characters long, which is substantial and contains actual financial data and analysis for a quarterly period. This matches the definition of an Interim / Quarterly Report (IR). Although it is called an "Earnings Presentation," the content goes beyond a simple presentation and includes comprehensive financial tables and management discussion, which fits the IR category better than just an Investor Presentation (IP) or Earnings Release (ER). Therefore, the most appropriate classification is Interim / Quarterly Report (IR). Q1 2026
2025-08-02 English
Record Date
Regulatory Filings Classification · 85% confidence The document is an official SEBI Listing Regulations disclosure under Regulation 30, detailing the outcome of a board meeting, including approval of quarterly unaudited financial results (with limited review), notices for the AGM, record dates, dividend eligibility, directors’ retirement, appointments, and committee reconstitutions. It is a regulatory filing to stock exchanges rather than the full financial report itself, and serves as a general compliance announcement rather than the standalone quarterly report or a management presentation. Therefore, it best fits the Regulatory Filings (RNS) category.
2025-08-02 English
Outcome of Board Meeting
Regulatory Filings Classification · 85% confidence The document is an official announcement under SEBI Listing Regulations describing the outcome of a board meeting: approval of un-audited quarterly results, limited review report, directors’ report, MD&A, convening the AGM, record date for dividend, board and committee changes, and the auditor’s limited review report. It does not itself present full financial statements or serve as the interim report; instead, it is a regulatory disclosure/filing. It fits our “Regulatory Filings” category (RNS), which covers compliance announcements and board meeting outcomes under listing rules.
2025-08-02 English
General Updates
Regulatory Filings Classification · 85% confidence The document is a formal announcement to stock exchanges under SEBI Listing Regulations (Regulation 30/33) communicating the outcome of a Board meeting – approval of unaudited quarterly financial results and limited review, convening of the AGM, record dates, dividend, reappointments and retirements of directors, reconstitution of board committees and corporate guarantees. It is not the full interim report (the actual financials are in annexures), nor simply an earnings highlights release nor a standalone management-change notice. It is a multi-item compliance filing, fitting the fallback category for miscellaneous regulatory announcements to exchanges. Therefore, it should be classified as a Regulatory Filing (RNS).
2025-08-02 English
General Updates
Regulatory Filings Classification · 85% confidence The document is a Regulation 30 disclosure to the Indian stock exchanges outlining the outcome of a Board meeting: approval of quarterly unaudited results (with Limited Review report), approval of annual reports and AGM notice, declaration of record dates/dividend, corporate guarantee, management retirements and new appointments, and committee reconstitutions. It is not a standalone annual or interim report itself but a regulatory filing announcing these outcomes. No specific financial statements are presented in the main text, and it serves as a compliance announcement under SEBI Listing Regulations. Thus it falls under general regulatory filings.
2025-08-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.